{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:37:03Z","timestamp":1786736223224,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Cancer"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/ijc.ijc_373_17","type":"journal-article","created":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T05:45:40Z","timestamp":1567143940000},"page":"526","source":"Crossref","is-referenced-by-count":12,"title":["Advanced hepatocellular carcinoma: A regional cancer center experience of 48 cases"],"prefix":"10.4103","volume":"54","author":[{"given":"Tamojit","family":"Chaudhuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KN","family":"Lokesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KC","family":"Lakshmaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KGovind","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lokanatha","family":"Dasappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LinuAbraham","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MC","family":"Suresh Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AH","family":"Rudresha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LK","family":"Rajeev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0019-509X.233153-1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1634\/theoncologist.2010-S4-05","article-title":"The incidence and epidemiology of hepatocellular carcinoma: A global and regional perspective","author":"Venook","year":"2010","journal-title":"Oncologist"},{"key":"key-10.4103\/0019-509X.233153-2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"key-10.4103\/0019-509X.233153-3","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1016\/S1470-2045(14)70115-9","article-title":"The growing burden of cancer in India: Epidemiology and social context","author":"Mallath","year":"2014","journal-title":"Lancet Oncol"},{"key":"key-10.4103\/0019-509X.233153-4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/qjmed\/hcn033","article-title":"Characteristics of hepatocellular carcinoma in India: A retrospective analysis of 191 cases","author":"Kumar","year":"2008","journal-title":"QJM"},{"key":"key-10.4103\/0019-509X.233153-5","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1046\/j.1440-1746.2001.02476.x","article-title":"Profile of hepatocellular carcinoma in India: An insight into the possible etiologic associations","author":"Sarin","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"key-10.4103\/0019-509X.233153-6","first-page":"A57","article-title":"Viral markers in hepatocellular carcinoma","author":"Durga","year":"1994","journal-title":"Indian J Gastroenterol","ISSN":"https:\/\/id.crossref.org\/issn\/0254-8860","issn-type":"print"},{"key":"key-10.4103\/0019-509X.233153-7","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0019-509X.233153-8","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.ejca.2008.02.018","article-title":"The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma-Survival analysis of 3892 patients","author":"Wang","year":"2008","journal-title":"Eur J Cancer"},{"key":"key-10.4103\/0019-509X.233153-9","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: An update","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"key-10.4103\/0019-509X.233153-10","first-page":"908","article-title":"EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma","author":"European","year":"2012","journal-title":"J Hepatol"},{"key":"key-10.4103\/0019-509X.233153-11","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.3748\/wjg.v20.i15.4115","article-title":"Hepatocellular carcinoma review: Current treatment, and evidence-based medicine","author":"Raza","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key-10.4103\/0019-509X.233153-12","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1572-0241.2007.01712.x","article-title":"Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): The role of angiogenesis and invasiveness","author":"Sergio","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"key-10.4103\/0019-509X.233153-13","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1158\/1535-7163.MCT-08-0013","article-title":"Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling","author":"Wilhelm","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"key-10.4103\/0019-509X.233153-14","doi-asserted-by":"crossref","first-page":"e100305","DOI":"10.1371\/journal.pone.0100305","article-title":"Transarterial chemoembolization (TACE) plus sorafenib versus TACE for intermediate or advanced stage hepatocellular carcinoma: A meta-analysis","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"key-10.4103\/0019-509X.233153-15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5604\/16652681.1231585","article-title":"Combination of TACE and Sorafenib Improves Outcomes in BCLC Stages B\/C of Hepatocellular Carcinoma: A Single Centre Experience","author":"Varghese","year":"2017","journal-title":"Ann Hepatol"},{"key":"key-10.4103\/0019-509X.233153-16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.18203\/issn.2454-2156.IntJSciRep20150205","article-title":"Hepatocellular carcinoma in Eastern India, a detail analytical report from a tertiary cancer hospital","author":"Mukherjee","year":"2015","journal-title":"Int J Sci Rep"},{"key":"key-10.4103\/0019-509X.233153-17","first-page":"141","article-title":"Spectrum of hepatocellular carcinoma: Study from a tertiary cancer centre","author":"Nagaich","year":"2016","journal-title":"J Cancer Prev Curr Res"},{"key":"key-10.4103\/0019-509X.233153-18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.18203\/2320-6012.ijrms20170039","article-title":"Clinical profile of hepatocellular carcinoma and experience with sorafenib from a tertiary cancer centre in Southern India","author":"Nandennavar","year":"2017","journal-title":"Int J Res Med Sci"},{"key":"key-10.4103\/0019-509X.233153-19","doi-asserted-by":"crossref","unstructured":"Kostner AH, Sorensen M, Olesen RK, Gronbaek H, Lassen U, Ladekarl M. Sorafenib in advanced hepatocellular carcinoma: A nationwide retrospective study of effi cacy and tolerability. Sci World J 2013; p. 6.","DOI":"10.1155\/2013\/931972"},{"key":"key-10.4103\/0019-509X.233153-20","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12885-015-1273-2","article-title":"Clinical outcomes of patients with hepatocellular carcinoma treated with sorafenib: A retrospective study of routine clinical practice in multiinstitutions","author":"Lee","year":"2015","journal-title":"BMC Cancer"}],"container-title":["Indian Journal of Cancer"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:39:07Z","timestamp":1786732747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijc.IJC_373_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"alternative-id":["233153"],"URL":"https:\/\/doi.org\/10.4103\/ijc.ijc_373_17","relation":{},"ISSN":["0019-509X"],"issn-type":[{"value":"0019-509X","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}